Immunohistochemistry demonstrated lack of ATRX (alpha thalassemia/mental retardation syndrome X-linked) protein in tumor cells, indicating an <i>ATRX</i> gene mutation. This evidence concerns the gene ATRX and Alpha-thalassemia.